Logotype for MDxHealth SA

MDxHealth (MDXH) investor relations material

MDxHealth Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for MDxHealth SA
Q3 2025 earnings summary12 Nov, 2025

Executive summary

  • Q3 2025 revenue rose 18% year-over-year to $27.4 million, with adjusted EBITDA of $1 million and positive adjusted EBITDA year-to-date.

  • Net loss for Q3 improved 28% year-over-year to $8 million; nine-month net loss improved 21% to $24.6 million.

  • Closed the ExoDx acquisition, expanding the precision diagnostics portfolio and salesforce from 50 to 60 reps across eight regions.

  • Focused on integrating ExoDx, optimizing cross-selling, and converting SelectMDx customers to ExoDx by year-end.

  • Operating expenses remained flat year-over-year, despite $1.5 million in acquisition-related costs.

Financial highlights

  • Q3 billable volume reached 33,000 tests (13,000 tissue-based, 20,000 liquid-based), up 37% year-over-year.

  • Gross profit was $17.9 million, up 25% from Q3 2024; gross margin improved to 65.2% from 61.2%.

  • Tissue-based test volumes grew 18%, liquid-based tests grew 65% year-over-year.

  • Cash and cash equivalents stood at $32 million as of September 30, 2025.

  • Operating loss declined 57% to $2.6 million; net loss per share improved to $(0.16) from $(0.40) year-over-year.

Outlook and guidance

  • 2025 revenue guidance reaffirmed at $108–$110 million, with ExoDx expected to offset the loss of germline and SelectMDx revenues.

  • ExoDx anticipated to contribute $20 million or more in 2026, potentially accelerating revenue growth to near 30%.

  • Gross margin expected to remain strong, with ExoDx integration likely neutral to accretive.

  • Germline market opportunity will be reevaluated in 2026.

  • Full-year revenue growth of at least 20% expected.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next MDxHealth earnings date

Logotype for MDxHealth SA
Q4 202525 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next MDxHealth earnings date

Logotype for MDxHealth SA
Q4 202525 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

MDxHealth SA is a molecular diagnostics company focused on the development and commercialization of genomic tests for cancer. Specializing in urologic oncology, the company provides non-invasive tests that assist in the diagnosis and management of prostate and bladder cancers. MDxHealth’s tests use epigenetic and genetic markers to deliver accurate, personalized insights that support healthcare providers in making informed treatment decisions. The company is headquartered in Herstal, Belgium, and its shares are listed on the Euronext Brussels and the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage